FIELD: medicine, pharmaceutics.
SUBSTANCE: invention describes a group of substituted N-phenylbipyrrolidincarboxamides of formula 
(I), where m equals 1 or 2; n equals to 1 or 2; p equals to 1 or 2; R1 is hydrogen, (C1-C4)-alkyl, CF3, (C1-C4)-alkoxy-(C1-C4)-alkyl; and R2 is hydrogen, halogen, (C1-C4)-alkyl or CF3; or their salt, or enantiomer, or diastereomer. In particular, compounds in accordance with the invention are modulators of H3 receptors and, therefore, are suitable for application as pharmaceutical preparations, in particular, in treatment and (or) prevention of different diseases, modulated by H3 receptors, including diseases associated with the central nervous system.
EFFECT: obtained are novel compounds, possessing useful biological properties.
15 cl, 1 tbl, 44 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SPIRO-FUSED PIPERIDINE DERIVATIVES FOR APPLICATION AS INHIBITORS OF EXTERNAL MEDULLAR LAYER POTASSIUM CHANNEL | 2013 |
|
RU2642066C2 |
| SUBSTITUTED N-PHENYLBIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF | 2008 |
|
RU2477720C2 |
| SUBSTITUTED N-PHENYLBIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF | 2008 |
|
RU2477719C2 |
| CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DESTRUCTION OF ANDROGEN RECEPTORS AND USE THEREOF | 2020 |
|
RU2825000C2 |
| C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | 2017 |
|
RU2716502C2 |
| MACROCYCLIC PYRIDAZINONE DERIVATIVES | 2014 |
|
RU2660435C2 |
| SPIROAZACYCLIC COMPOUNDS, METHOD FOR INHIBITION IF ACTIVITY OR ACTIVATION OF SEROTONIN 5-НТ2А RECEPTOR, METHOD FOR TREATMENT OF MORBID STATE ASSOCIATED WITH SEROTONIN 5-НТ2А RECEPTOR AND THEIR USING | 2002 |
|
RU2315051C2 |
| BICYCLIC NITROGEN-CONTAINING COMPOUNDS AS MUSCARINIC M1 RECEPTOR AGONISTS | 2015 |
|
RU2685230C2 |
| NOVEL BENZOTHIAZINONE DERIVATIVES AND USE THEREOF AS ANTIBACTERIAL AGENTS | 2006 |
|
RU2395508C1 |
| SUBSTITUTED N-PHENYL-BIPYRROLIDINE UREAS AND THERAPEUTIC USE THEREOF | 2008 |
|
RU2478094C2 |
